Health, Medical & Pharma News - Updated Daily page 98

Statins May Reduce Risk for Hepatocellular Carcinoma in Chronic Liver Disease

For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according t

Graph Neural Network Can Detect Epileptogenic Focal Cortical Dysplasia

A graph neural network using data from the Multicenter Epilepsy Lesion Detection (MELD) Project (MELD Graph) can detect epileptogenic focal cortical dysplasia (

Prevalence of Pediatric-Onset Chronic Conditions, Functional Limitations Increasing

The prevalence of chronic conditions (CC) and functional limitations (FL) is increasing among children and young adults, according to a study published online M

Few Nonsurgical Treatments Show Effectiveness for Low Back Pain

For acute low back pain, there is moderate-certainty evidence that nonsteroidal anti-inflammatory drugs are an effective treatment, while there is moderate-cert

Tirzepatide, Semaglutide Not Cost-Effective at Current Prices

Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study published online March 14 in JAMA Health Forum. Jen

Weed Users At Greater Risk For Heart Attack, Stroke

Weed users are much more likely to suffer a heart attack, stroke or other life-threatening heart condition than people who don t indulge, a new study says. Adul

Rare Hair Loss Condition Can Be Treated With Low Doses Of Antibiotic

Lower doses of a common antibiotic can curb hair loss caused by a rare skin condition, a new study says. The antibiotic doxycycline is commonly used to treat ly

Where You Live Can Influence Recovery From Brain Injury

Where a person lives can influence their recovery from a traumatic brain injury, a new study says. Based on their neighborhood s characteristics, people are les

Firearms Rarely Used For Protection Against Crime

People often say they own a gun to protect themselves and their families. But firearms owners rarely use their weapon in self-defense, a new study says. say the

Nipocalimab, the First and Only Investigational Treatment to be Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults with Moderate-to-Severe Sjögren’s Disease, has now Received Fast Track Designation

SPRING HOUSE, Pa., (March 18, 2025) Johnson Johnson (NYSE JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted investigational nipo

Pharmaceutical News and Articles